Track ANG Lifesciences India Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: -8.66 %
Low
30.6
High
33.8
1 Month returns: -7.97 %
Low
30.6
High
37.5
1 Year returns: 3.87 %
Low
17.6
High
49.7
3 Year CAGR: -22.56 %
Low
17.6
High
86.1
5 Year CAGR: -30.88 %
Low
17.6
High
640.4
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for ANG Lifesciences India Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
ANG Lifesciences India Ltd. Shareholding Pattern
Quarterly breakdown of ANG Lifesciences India Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in ANG Lifesciences India Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of ANG Lifesciences India Ltd.?
The current share price of ANG Lifesciences India Ltd. is ₹ 30.60 as of 12 Aug 2026.
What is the market capitalisation of ANG Lifesciences India Ltd.?
The market capitalisation of ANG Lifesciences India Ltd. stands at ₹ 39.96 Cr.
What is the PE ratio of ANG Lifesciences India Ltd.?
The Price-to-Earnings (PE) ratio of ANG Lifesciences India Ltd. is - as of the latest trailing twelve months data.
What is the ROE and ROCE of ANG Lifesciences India Ltd.?
ANG Lifesciences India Ltd. has a Return on Equity (ROE) of -18.97% and a Return on Capital Employed (ROCE) of -4.02% as per the latest financial reports.
What is the 52-week high and low of ANG Lifesciences India Ltd.?
The 52-week high of ANG Lifesciences India Ltd. is - and the 52-week low is -.
What is the dividend yield of ANG Lifesciences India Ltd.?
The dividend yield of ANG Lifesciences India Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in ANG Lifesciences India Ltd.?
Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 29.18% of ANG Lifesciences India Ltd. shares.
What sector does ANG Lifesciences India Ltd. belong to?
ANG Lifesciences India Ltd. operates in the Healthcare sector.
What is the beta of ANG Lifesciences India Ltd.?
The beta of ANG Lifesciences India Ltd. is 0.49, indicating its price volatility relative to the broader market. Over the past 1 year, ANG Lifesciences India Ltd. has delivered an absolute return of -3.50%.
What is the RSI of ANG Lifesciences India Ltd.?
The 14-day Relative Strength Index (RSI) of ANG Lifesciences India Ltd. is 39.43, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of ANG Lifesciences India Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Not enough talking points with positive stance
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis
Earnings yield of -27.74% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis
What is Earnings yield (E/P)?
Low dividend yield
The company has a low dividend yield of 0.0%
What is Dividend yield?
Neutral
Not enough talking points with neutral stance
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0123308.
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Name
Month
Transaction
Holding % pre transaction
Average price
Qty.
Transaction value
Rajesh Gupta
Promoter Group
August-2021
Market Purchase (Acquisition)
12th Aug 2021
70.81 %
₹ 440.00
3.20 k
₹ 14.08 lac
Company Profile
Overview of ANG Lifesciences India Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
ANG Lifesciences India Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials. It operates in two segments, namely pharmaceuticals and printing and packaging. The Companys product portfolio includes various products comprising therapeutic categories, such as Antibiotics, Antiviral, Antimalarial, Antiulcer, Carbapenem, Corticosteroid, Penicillin and Beta Lactamase Inhibitor. The Company’s product category includes Dry Powder Injection, Liquid Injections, Hard Gelatin Capsule, Tablet Beta Lactum, Tablets, Liquid Suspension /Syrup, Ointment/Creams, and Soft Gelatin Capsule. Its Dry Powder Injection products include Ampicillin & Cloxacillin for injection 500mg, Azetronam for Injection USP 500mg, Ampicillin Injection 1.0gm, Ceftriaxone Injection 250mg, Amoxycillin & Potassium Clavulanate for injection 1.2gm, and others.
ANG Lifesciences India Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials. It operates in two segments, namely pharmaceuticals and print...